Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 83 items for :

  • antidiabetic drugs x
Clear All
Zhenyu Liu Department of Clinical Medicine, Beijing Luhe Hospital, Capital Medical University, Tongzhou District, Beijing, China

Search for other papers by Zhenyu Liu in
Google Scholar
PubMed Close
,
Huixi Kong Department of Clinical Medicine, Beijing Shijitan Hospital, Capital Medical University, Haidian District, Beijing, China

Search for other papers by Huixi Kong in
Google Scholar
PubMed Close
, and
Baoyu Zhang Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Tongzhou District, Beijing, China

Search for other papers by Baoyu Zhang in
Google Scholar
PubMed Close

with T2DM ( 15 , 16 ). Thus, to optimize the treatment plan, antidiabetic drugs that can reduce SUA levels are required to achieve comprehensive control in patients with T2DM and hyperuricemia. Therefore, this review aimed to summarize how antidiabetic

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-24-0070
Volume/Issue:
Volume 13: Issue 6
Open access
Eva Olga Melin Department of Clinical Sciences, Endocrinology and Diabetes, Lund University, Faculty of Medicine, Lund, Sweden
Department of Research and Development, Region Kronoberg, Växjö, Sweden
Region Kronoberg, Primary Care, Växjö, Sweden

Search for other papers by Eva Olga Melin in
Google Scholar
PubMed Close
,
Jonatan Dereke Department of Clinical Sciences Lund, Lund University, Faculty of Medicine, Diabetes Research Laboratory, Lund, Sweden

Search for other papers by Jonatan Dereke in
Google Scholar
PubMed Close
,
Maria Thunander Department of Clinical Sciences, Endocrinology and Diabetes, Lund University, Faculty of Medicine, Lund, Sweden
Department of Research and Development, Region Kronoberg, Växjö, Sweden
Department of Internal Medicine, Endocrinology and Diabetes, Central Hospital, Växjö, Sweden

Search for other papers by Maria Thunander in
Google Scholar
PubMed Close
, and
Magnus Hillman Department of Clinical Sciences Lund, Lund University, Faculty of Medicine, Diabetes Research Laboratory, Lund, Sweden

Search for other papers by Magnus Hillman in
Google Scholar
PubMed Close

the prevalence of self-reported depression, abdominal obesity, general obesity, physical inactivity, smoking, cardiovascular complications, antidepressants, oral antidiabetic drugs (OADs) in addition to insulin, lipid lowering drugs (LLDs) or

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0108
Volume/Issue:
Volume 7: Issue 6
Open access
Lisa Arnetz Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes

Search for other papers by Lisa Arnetz in
Google Scholar
PubMed Close
,
Neda Rajamand Ekberg Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes

Search for other papers by Neda Rajamand Ekberg in
Google Scholar
PubMed Close
,
Kerstin Brismar Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes

Search for other papers by Kerstin Brismar in
Google Scholar
PubMed Close
, and
Michael Alvarsson Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes

Search for other papers by Michael Alvarsson in
Google Scholar
PubMed Close

from all patients before inclusion in the study. Patients with T2D were allowed to take oral antidiabetic drugs (OADs). Exclusion criteria were insulin or glucocorticoid therapy. One male patient with T2D was excluded from the analyses before and after

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-15-0003
Volume/Issue:
Volume 4: Issue 2
Open access
Josephina G Kuiper PHARMO Institute for Drug Outcomes Research, AE Utrecht, Netherlands
Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands

Search for other papers by Josephina G Kuiper in
Google Scholar
PubMed Close
,
Aline C Fenneman Department of Clinical and Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Search for other papers by Aline C Fenneman in
Google Scholar
PubMed Close
,
Anne H van der Spek Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Search for other papers by Anne H van der Spek in
Google Scholar
PubMed Close
,
Elena Rampanelli Department of Clinical and Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Search for other papers by Elena Rampanelli in
Google Scholar
PubMed Close
,
Max Nieuwdorp Department of Clinical and Experimental Vascular Medicine, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Search for other papers by Max Nieuwdorp in
Google Scholar
PubMed Close
,
Myrthe P P van Herk-Sukel Department of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, Netherlands

Search for other papers by Myrthe P P van Herk-Sukel in
Google Scholar
PubMed Close
,
Valery E P P Lemmens Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands
Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands

Search for other papers by Valery E P P Lemmens in
Google Scholar
PubMed Close
,
Ernst J Kuipers Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands

Search for other papers by Ernst J Kuipers in
Google Scholar
PubMed Close
,
Ron M C Herings PHARMO Institute for Drug Outcomes Research, AE Utrecht, Netherlands
Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, Netherlands

Search for other papers by Ron M C Herings in
Google Scholar
PubMed Close
, and
Eric Fliers Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Search for other papers by Eric Fliers in
Google Scholar
PubMed Close

that potentially decrease the risk of CRC including use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), statins, antidiabetics (both oral antidiabetics and insulin), hormone replacement therapy, and oral contraceptives. Non-users of

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0463
Volume/Issue:
Volume 11: Issue 1
Open access
Mônica R Gadelha Endocrine Unit, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed Close
,
Feng Gu Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Beijing, China

Search for other papers by Feng Gu in
Google Scholar
PubMed Close
,
Marcello D Bronstein Neuroendocrine Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School, São Paulo, Brazil

Search for other papers by Marcello D Bronstein in
Google Scholar
PubMed Close
,
Thierry C Brue Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale, Marseille Medical Genetics, and Assistance Publique Hôpitaux de Marseille, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l’Hypophyse, Marseille, France

Search for other papers by Thierry C Brue in
Google Scholar
PubMed Close
,
Maria Fleseriu Northwest Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA

Search for other papers by Maria Fleseriu in
Google Scholar
PubMed Close
,
Ilan Shimon Institute of Endocrinology and Metabolism, Rabin Medical Center, and Sackler School of Medicine, Tel-Aviv University, Petah-Tiqva, Israel

Search for other papers by Ilan Shimon in
Google Scholar
PubMed Close
,
Aart J van der Lely Erasmus University Medical Center, Rotterdam, The Netherlands

Search for other papers by Aart J van der Lely in
Google Scholar
PubMed Close
,
Shoba Ravichandran Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA

Search for other papers by Shoba Ravichandran in
Google Scholar
PubMed Close
,
Albert Kandra Recordati AG, Basel, Switzerland

Search for other papers by Albert Kandra in
Google Scholar
PubMed Close
,
Alberto M Pedroncelli Recordati AG, Basel, Switzerland

Search for other papers by Alberto M Pedroncelli in
Google Scholar
PubMed Close
, and
Annamaria A L Colao Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy

Search for other papers by Annamaria A L Colao in
Google Scholar
PubMed Close

during study C2402. This group is not shown because of difficulties interpreting the median for two patients. FPG, fasting plasma glucose; HbA 1c , glycated hemoglobin; OAD, oral antidiabetic drug. Reversibility of hyperglycemia The

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0361
Volume/Issue:
Volume 9: Issue 12
Open access
Peter Wolf Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Peter Wolf in
Google Scholar
PubMed Close
,
Alexandre Dormoy Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Alexandre Dormoy in
Google Scholar
PubMed Close
,
Luigi Maione Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Luigi Maione in
Google Scholar
PubMed Close
,
Sylvie Salenave Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Sylvie Salenave in
Google Scholar
PubMed Close
,
Jacques Young Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Jacques Young in
Google Scholar
PubMed Close
,
Peter Kamenický Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Peter Kamenický in
Google Scholar
PubMed Close
, and
Philippe Chanson Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Philippe Chanson in
Google Scholar
PubMed Close

with GLP-1 analogs might be superior, as incretin secretion is suppressed by pasireotide, which might limit the effectiveness of DPP-4 inhibitors ( 34 ). However, due to the limited number of patients treated with different antidiabetic drugs in the

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0296
Volume/Issue:
Volume 11: Issue 12
Open access
Po-Chung Cheng Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan

Search for other papers by Po-Chung Cheng in
Google Scholar
PubMed Close
and
Chia-Hung Kao Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan

Search for other papers by Chia-Hung Kao in
Google Scholar
PubMed Close

2DM ( 11 ). Therefore, investigators have proposed that postprandial hyperglycemia may be a risk factor of diabetic CHD ( 12 ). Telemedicine is a complementary therapeutic modality in the treatment of T2DM. Conventional antidiabetic therapy based

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0209
Volume/Issue:
Volume 10: Issue 7
Open access
Agnieszka Adamska Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed Close
,
Vitalii Ulychnyi Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Vitalii Ulychnyi in
Google Scholar
PubMed Close
,
Katarzyna Siewko Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed Close
,
Anna Popławska-Kita Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Anna Popławska-Kita in
Google Scholar
PubMed Close
,
Małgorzata Szelachowska Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland

Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed Close
,
Marcin Adamski Faculty of Computer Science, Bialystok University of Technology, Białystok, Poland

Search for other papers by Marcin Adamski in
Google Scholar
PubMed Close
,
Angelika Buczyńska Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Angelika Buczyńska in
Google Scholar
PubMed Close
, and
Adam Jacek Krętowski Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Bialystok, Poland
Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland

Search for other papers by Adam Jacek Krętowski in
Google Scholar
PubMed Close

, antidiabetic and hypolipidemic drugs in patients with NFAT and MACS. Data are present as a mean (minimum-maximum) and in percent. NFAT ( n   = 239) MACS ( n   = 56) P Duration of hypertension (years) 3.6 (0–30) 5 (0–30) 0

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-22-0074
Volume/Issue:
Volume 11: Issue 9
Open access
Niels B Dalsgaard Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Niels B Dalsgaard in
Google Scholar
PubMed Close
,
Lærke S Gasbjerg Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Lærke S Gasbjerg in
Google Scholar
PubMed Close
,
Laura S Hansen Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Laura S Hansen in
Google Scholar
PubMed Close
,
Dennis S Nielsen Department of Food Science, Faculty of Science, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Dennis S Nielsen in
Google Scholar
PubMed Close
,
Torben S Rasmussen Department of Food Science, Faculty of Science, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Torben S Rasmussen in
Google Scholar
PubMed Close
, and
Filip K Knop Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark

Search for other papers by Filip K Knop in
Google Scholar
PubMed Close

. Gut microbiota and antidiabetic drugs: perspectives of personalized treatment in type 2 diabetes mellitus . Frontiers in Cellular and Infection Microbiology 2022 12 853771 . ( https://doi.org/10.3389/fcimb.2022.853771 ) 26 Vandeputte D Kathagen

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-24-0052
Volume/Issue:
Volume 13: Issue 7
Open access
Lili Liu Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China

Search for other papers by Lili Liu in
Google Scholar
PubMed Close
,
Zhuo Shao Department of General Surgery, Changhai Hospital, The Second Military Medical University, Shanghai, Shanghai, China

Search for other papers by Zhuo Shao in
Google Scholar
PubMed Close
,
Ying Xia Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China

Search for other papers by Ying Xia in
Google Scholar
PubMed Close
,
Jiabi Qin Department of Epidemiology & Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China

Search for other papers by Jiabi Qin in
Google Scholar
PubMed Close
,
Yang Xiao Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China

Search for other papers by Yang Xiao in
Google Scholar
PubMed Close
,
Zhiguang Zhou Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China

Search for other papers by Zhiguang Zhou in
Google Scholar
PubMed Close
, and
Zubing Mei Department of Anorectal Surgery, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Search for other papers by Zubing Mei in
Google Scholar
PubMed Close

is the most accurate and comprehensive meta-analysis of incretin-based therapy without other classified antidiabetic drugs in T1DM. In 2016, Guo et al . ( 35 ) conducted a meta-analysis of six RCTs investigating the efficacy and safety of DPP-4

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0546
Volume/Issue:
Volume 8: Issue 3
Open access